Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S de Bono

Showing results (91-100 of 492) with videos related to

Pageof 50
Sort By:
Nature Reviews. Cancer|June 11, 2010
Envisioning the future of early anticancer drug developmentTimothy A Yap, Shahneen K Sandhu, Paul Workman, et al.
Current Opinion in Pharmacology|July 16, 2008
Targeting CYP17: established and novel approaches in prostate cancerTimothy A Yap, Craig P Carden, Gerhardt Attard, et al.
European Urology|July 20, 2025
Novel Therapeutic Strategies for Metastatic Prostate Cancer CareAlessia Cimadamore, Cristina Boixareu, Adam Sharp, et al.
Expert Opinion on Drug Discovery|March 15, 2013
Targeting cell cycle kinases and kinesins in anticancer drug developmentTimothy A Yap, L Rhoda Molife, Sarah P Blagden, et al.
Oncogene|May 20, 2014
Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospectsR Ferraldeschi, J Welti, J Luo, et al.
Expert Opinion on Investigational Drugs|July 23, 2011
Targeting the insulin-like growth factor signaling pathway: figitumumab and other novel anticancer strategiesTimothy A Yap, David Olmos, Lulama Rhoda Molife, et al.
Journal of Musculoskeletal & Neuronal Interactions|March 31, 2007
Influence of birth weight on peripheral bone in young Gambian adults: a pQCT studyS de Bono, M A Laskey, M Ceesay, et al.
BMJ Open|November 28, 2022
What is the impact of targeted therapies given within phase I trials on the cognitive function of patients with advanced cancer: a mixed-methods exploratory study conducted in an early clinical trials unitSarah Stapleton, Anne-Sophie Emma Darlington, J S de Bono, et al.
Current Opinion in Oncology|April 6, 2012
Targeting the DNA damage response in oncology: past, present and future perspectivesBristi Basu, Timothy A Yap, L Rhoda Molife, et al.
European Urology|April 10, 2025
Reply to Felix Melchior, Andreas Pircher, and Isabel Heidegger's Letter to the Editor re: Johann S. de Bono, Meng He, Chen Shi, et al. Final Overall Survival and Molecular Data Associated with Clinical Outcomes in Patients Receiving Ipatasertib and Abiraterone in the Phase 3 IPATential150 Trial. Eur Urol. 2025;87:468-75Christopher Sweeney, Meng He, Matthew Wongchenko, et al.
Pageof 50

Showing results (91-100 of 492) with videos related to

Sort By:
Pageof 50
Nature Reviews. Cancer|June 11, 2010
Envisioning the future of early anticancer drug developmentTimothy A Yap, Shahneen K Sandhu, Paul Workman, et al.
Current Opinion in Pharmacology|July 16, 2008
Targeting CYP17: established and novel approaches in prostate cancerTimothy A Yap, Craig P Carden, Gerhardt Attard, et al.
European Urology|July 20, 2025
Novel Therapeutic Strategies for Metastatic Prostate Cancer CareAlessia Cimadamore, Cristina Boixareu, Adam Sharp, et al.
Expert Opinion on Drug Discovery|March 15, 2013
Targeting cell cycle kinases and kinesins in anticancer drug developmentTimothy A Yap, L Rhoda Molife, Sarah P Blagden, et al.
Oncogene|May 20, 2014
Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospectsR Ferraldeschi, J Welti, J Luo, et al.
Expert Opinion on Investigational Drugs|July 23, 2011
Targeting the insulin-like growth factor signaling pathway: figitumumab and other novel anticancer strategiesTimothy A Yap, David Olmos, Lulama Rhoda Molife, et al.
Journal of Musculoskeletal & Neuronal Interactions|March 31, 2007
Influence of birth weight on peripheral bone in young Gambian adults: a pQCT studyS de Bono, M A Laskey, M Ceesay, et al.
BMJ Open|November 28, 2022
What is the impact of targeted therapies given within phase I trials on the cognitive function of patients with advanced cancer: a mixed-methods exploratory study conducted in an early clinical trials unitSarah Stapleton, Anne-Sophie Emma Darlington, J S de Bono, et al.
Current Opinion in Oncology|April 6, 2012
Targeting the DNA damage response in oncology: past, present and future perspectivesBristi Basu, Timothy A Yap, L Rhoda Molife, et al.
European Urology|April 10, 2025
Reply to Felix Melchior, Andreas Pircher, and Isabel Heidegger's Letter to the Editor re: Johann S. de Bono, Meng He, Chen Shi, et al. Final Overall Survival and Molecular Data Associated with Clinical Outcomes in Patients Receiving Ipatasertib and Abiraterone in the Phase 3 IPATential150 Trial. Eur Urol. 2025;87:468-75Christopher Sweeney, Meng He, Matthew Wongchenko, et al.
Pageof 50